Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma

Abstract Vitreoretinal large B-cell lymphoma (VR-LBCL) is a rare hematologic malignancy. It is classified as primary (PVR-LBCL) or secondary (SVR-LBCL) based on the initial site of manifestation. Owing to limited prospective data and absent standardized guidelines, treatment remains challenging. Thi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sina A. Beer, Carola Huber, Emil Nasyrov, Lasse Wolfram, Martin Pietzsch, Aileen Schenk, Michael Sommer, Andreas Wedrich, Claudia Lengerke, Deshka Doycheva, Christoph Deuter, Daniela Süsskind, Stefan Wirths, David A. Merle
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2026-02-01
Edice:	Scientific Reports
Témata:	Vitreoretinal lymphoma Orphan disease Relapse-free survival PVRL PIOL
On-line přístup:	https://doi.org/10.1038/s41598-026-37804-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!